Physician profile
Dylan Ryan
NPI 1790326130
$26,425.92
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $371 · 2022: $20K · 2023: $5,521 · 2024: $129.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,150 · Travel and Lodging: $1,365 · Food and Beverage: $1,135.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,150.00 |
| Travel and Lodging | $1,364.72 |
| Food and Beverage | $1,134.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $24,137.57 | 2021-2023 | |
| Medical Device Business Services, INC. | $1,126.71 | 2023 | Stratafix |
| Abiomed | $344.87 | 2023-2024 | Impella |
| Atricure, INC. | $265.75 | 2022-2024 | |
| Haemonetics Corporation | $212.22 | 2021-2023 | Teg6s Hemostasis System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $159.51 | 2021-2023 | Lifevest |
| Getinge USA Sales, LLC | $139.24 | 2023 | Vasoview Hemopro 2 |
| Baxter Healthcare | $25.18 | 2022 | |
| Abbvie INC. | $14.87 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dylan Ryan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.